| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addressing the tumour microenvironment in early drug discovery: a strategy to overcome drug resistance and identify novel targets for cancer therapy
|
Kaemmerer, Elke
|
|
|
26 |
3 |
p. 663-676
|
artikel
|
| 2 |
Advanced machine-learning techniques in drug discovery
|
Elbadawi, Moe
|
|
|
26 |
3 |
p. 769-777
|
artikel
|
| 3 |
Advances in 3D neural, vascular and neurovascular models for drug testing and regenerative medicine
|
Fernandes, Diogo C.
|
|
|
26 |
3 |
p. 754-768
|
artikel
|
| 4 |
Allosteric binding sites at the receptor–lipid bilayer interface: novel targets for GPCR drug discovery
|
Wang, Ying
|
|
|
26 |
3 |
p. 690-703
|
artikel
|
| 5 |
A review of in vitro and in vivo methods and their correlations to assess mouthfeel of solid oral dosage forms
|
Asiri, Abdullah
|
|
|
26 |
3 |
p. 740-753
|
artikel
|
| 6 |
Cell microencapsulation technologies for sustained drug delivery: Clinical trials and companies
|
Lopez-Mendez, Tania B.
|
|
|
26 |
3 |
p. 852-861
|
artikel
|
| 7 |
Contents page 1
|
|
|
|
26 |
3 |
p. i
|
artikel
|
| 8 |
Contents page 2
|
|
|
|
26 |
3 |
p. ii
|
artikel
|
| 9 |
Emerging paradigms in treating cerebral infarction with nanotheranostics: opportunities and clinical challenges
|
Almalki, Waleed H.
|
|
|
26 |
3 |
p. 826-835
|
artikel
|
| 10 |
Expanding small-molecule target space to mRNA translation regulation
|
Alroy, Iris
|
|
|
26 |
3 |
p. 786-793
|
artikel
|
| 11 |
Extracellular vesicles in blood: are they viable as diagnostic and predictive tools in breast cancer?
|
Daly, Róisín
|
|
|
26 |
3 |
p. 778-785
|
artikel
|
| 12 |
Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy
|
Yang, Chengcan
|
|
|
26 |
3 |
p. 817-825
|
artikel
|
| 13 |
In vivo therapeutic applications of phosphorus dendrimers: state of the art
|
Mignani, Serge
|
|
|
26 |
3 |
p. 677-689
|
artikel
|
| 14 |
Mainstream psychiatry reinstates therapeutic ventures of the remote past
|
Ovsepian, Saak V.
|
|
|
26 |
3 |
p. 845-851
|
artikel
|
| 15 |
Modelling the World – can deliberately infecting healthy volunteers really tell us much about what happens outside the clinic during an epidemic or pandemic?
|
Wildfire, Adrian
|
|
|
26 |
3 |
p. 617-619
|
artikel
|
| 16 |
Modulating target engagement of small molecules via drug delivery: approaches and applications in drug discovery and development
|
Yang, Wenzhan
|
|
|
26 |
3 |
p. 713-723
|
artikel
|
| 17 |
Nanodelivery of immunogenic cell death-inducers for cancer immunotherapy
|
Sun, Dandan
|
|
|
26 |
3 |
p. 651-662
|
artikel
|
| 18 |
Nanomedicine-driven molecular targeting, drug delivery, and therapeutic approaches to cancer chemoresistance
|
Khot, Vishwajeet M.
|
|
|
26 |
3 |
p. 724-739
|
artikel
|
| 19 |
NUDT5 as a novel drug target and prognostic biomarker for ER-positive breast cancer
|
Tong, Xin-Yu
|
|
|
26 |
3 |
p. 620-625
|
artikel
|
| 20 |
Potential SARS-CoV-2 main protease inhibitors
|
Banerjee, Riddhidev
|
|
|
26 |
3 |
p. 804-816
|
artikel
|
| 21 |
Recent developments of human monocarboxylate transporter (hMCT) inhibitors as anticancer agents
|
Wu, Puhua
|
|
|
26 |
3 |
p. 836-844
|
artikel
|
| 22 |
Road to effective data curation for translational research
|
Gu, Wei
|
|
|
26 |
3 |
p. 626-630
|
artikel
|
| 23 |
Role of reactive oxygen species in the progression of Alzheimer’s disease
|
Bhatt, Shvetank
|
|
|
26 |
3 |
p. 794-803
|
artikel
|
| 24 |
Therapeutic strategies against autophagic escape by pathogenic bacteria
|
Sharma, Saroj
|
|
|
26 |
3 |
p. 704-712
|
artikel
|
| 25 |
Toward in vivo relevant drug design
|
Pearlstein, Robert A.
|
|
|
26 |
3 |
p. 637-650
|
artikel
|
| 26 |
Why do we lack a specific magic anti-COVID-19 drug? Analyses and solutions
|
Lin, Min
|
|
|
26 |
3 |
p. 631-636
|
artikel
|
Tijdschrift beschrijving